Immune-Path (Yidao Biotechnology (Suzhou) Co., Ltd. / 怡道生物) is a China-based vaccine biotechnology company founded in 2017 and headquartered in Suzhou. The company develops human vaccines across recombinant protein antigen, novel viral vector, and messenger RNA (mRNA) platforms, backed by its own vaccine adjuvant technology. - View it on GitHub